This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Zika Vaccine Program (Valneva)
Drug Names(s): Zika Vaccine (Valneva)
Description: Valneva is developing a Zika vaccine.
Zika Vaccine Program (Valneva) News
Pink Sheet Zika Vaccines Might Be Approved By 2020
Additional information available to subscribers only: